Along with the latest market updates in this section of Global Pharma Management you can view the positioning of the Pharmaceutical companies and their financial updates within the Pharmaceutical Sector.
|
|
Tuesday, 09 March 2010 |
Jazz Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2009. ... |
|
Read more...
|
|
|
Tuesday, 09 March 2010 |
Penwest Pharmaceuticals Co. announced its financial results for the fourth quarter and full year ended December 31, 2009. Compared with the fourth quarter of 2008, fourth quarter 2009 revenues inc... |
|
Read more...
|
|
|
Monday, 08 March 2010 |
DUSA Pharmaceuticals, Inc., a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, repor... |
|
Read more...
|
|
|
Tuesday, 02 March 2010 |
Isis Pharmaceuticals, Inc. announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro... |
|
Read more...
|
|
|
Tuesday, 02 March 2010 |
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid ... |
|
Read more...
|
|
|
Thursday, 25 February 2010 |
Watson Pharmaceuticals, Inc. reported net revenue for the fourth quarter ended December 31, 2009 climbed 22 percent to $785.7 million, compared to $645.2 million in the fourth quarter 2008. Watson'... |
|
Read more...
|
|
|
Tuesday, 23 February 2010 |
CEL-SCI Corporation reports financial results for the quarter ended December 31, 2009. CEL-SCI reported that net income available to shareholders for the quarter ended December 31, 2009 was $19,... |
|
Read more...
|
|
|
Tuesday, 23 February 2010 |
XenoPort, Inc. reported its financial results for the fourth quarter and year ended December 31, 2009. Revenues for the quarter were $5.8 million, compared to $10.6 million for the same period i... |
|
Read more...
|
|
|
Thursday, 18 February 2010 |
Genzyme Corp., a diversified, global biotechnology company, announced fourth-quarter and full year 2009 financial results and provided 2010 guidance that reflects growth across its businesses an... |
|
Read more...
|
|
|
Thursday, 18 February 2010 |
Cipher Pharmaceuticals Inc. announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2009. |
|
Read more...
|
|
|
<< Start < Prev 1 2 Next > End >>
|
| Results 1 - 10 of 19 |